NovaSom

About:

NovaSom provides obstructive sleep apnea home testing devices with cardio-respiratory monitoring ability.

Twitter/X: novasom

Top Investors: Safeguard Scientifics, Armentum Partners, Quaker BioVentures

Description:

NovaSom, Inc. is a privately held diagnostic-service provider for home testing and evaluation of sleep-disordered breathing, which includes the diagnosis of obstructive sleep apnea (OSA). The company is a Medicare-approved Independent Diagnostic Testing Facility (IDTF) and is fully accredited as both an Ambulatory Care Sleep Diagnostic Center and as a Telehealth provider by The Joint Commission. The home testing system manufactured and distributed by NovaSom has FDA clearance for the diagnostic evaluation of OSA in adults. NovaSom has integrated their home sleep testing system into a cloud-based, collaborative patient management platform for physicians and payers. It is based in Glen Burnie, Maryland, the company was incorporated in 1992.

Total Funding Amount:

$70.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Glen Burnie, Maryland, United States

Founded Date:

1992-01-01

Contact Email:

info(AT)novasom.com

Founders:

Number of Employees:

51-100

Last Funding Date:

2018-01-01

IPO Status:

Private

Industries: